|
Back to Home » October 2012 News » Smaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and Treatments |
Smaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and Treatments |
October 29, 2012
The Paragon Report Provides Stock Research on Ariad Pharmaceuticals and Galena Biopharma
Source URL: http://www.marketwire.com/mw/release.do?id=1718780&sourceType=3
|
|
|
|
